IP Verse

Swedish Orphan Biovitrum Ab competitive analysis

Latest oppositions filed by Swedish Orphan Biovitrum Ab

Explore patent oppositions filed by Swedish Orphan Biovitrum Ab against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 22, 2026
Patent NumberTitleApplicantOpposition Date
EP3564267
Proteolytically Cleavable Fusion Proteins With High Molar Specific ActivityCSL BEHRING GMBHDec 17, 2021
EP3225233
Sodium Chloride Solution For Drug Reconstitution Or DilutionWYETHMay 14, 2020
EP2256135
Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation FactorCSL BEHRING GMBHDec 13, 2019

Latest PTAB cases involving Swedish Orphan Biovitrum Ab

Discover the latest PTAB cases involving Swedish Orphan Biovitrum Ab, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Swedish Orphan Biovitrum Ab with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 22, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BIOVERATIV THERAPEUTICS, INC./SWEDISH ORPHAN BIOVITRUM AB (PUBL)1 - - -
CSL BEHRING GMBH744 -